Apr 29, 2019 4:52 PM
FDA issued recall of bevacizumab 1.25mg/0.05mL 31G injectable by AmEx Pharmacy due to reported defective delivery system.
More on the FDA website:
www.fda.gov/safety/recalls-market-withdrawals-
safety-alerts/amex-pharmacy-issues-voluntary-nationwide
-recall-one-lot-bevacizumab-125mg005ml-31-g-syringe-due